ABPI Logo
  • Developing medicines
    • Responding to COVID-19
    • Clinical trials and research
    • Building a thriving environment for medicine discovery
    • UK-EU Future Relationship
    • Life Sciences Industrial Strategy
    • ABPI Medical Representatives Exam
  • Accessing medicines
    • How medicines are priced in the UK
    • Working with the NHS
    • Supply chain
    • Antimicrobial resistance (AMR)
    • Vaccines
    • What is the NICE Methods Review?
    • Rare diseases: Facing three challenges
  • Our ethics
    • ABPI Code of Practice
    • Disclosure UK
    • Appropriate prescribing
    • Patient & public involvement
  • Member representation
    • Events
    • Full membership
    • Working with our members​
    • ABPI Members List
    • Membership benefits
  • Who We Are
  • Media
  • Publications
  • Facts and Figures
  • Contact Us
MY ABPI LOGIN
 
  • The Association of the British Pharmaceutical Industry
  • Publications Library
  • ABPI Cymru Wales Winter Bulletin 2019

ABPI Cymru Wales Winter Bulletin 2019

Publication date: 04 Mar 2019

Contents:

  • The NHS and pharmaceutical industry working together to transform patient care – Welsh NHS Confederation Conference 2019
  • Metastatic Breast Cancer (MBC) – Velindre NHS University Trust and Novartis Working Together
  • How Wales is getting it right with Prudent Healthcare
  • The role of medicines in a Prudent NHS
  • Janssen, Welsh Government and NHS Wales Joint Working Initiative
  • Velindre Cancer Centre and Bristol Myers Squibb Pharmaceuticals Limited Immuno-Oncology Joint Working Project
  • Local campaign targets unused medicines and incorrectly recycled inhalers
  • A new era of partnership to deliver the best for patients
  • Promoting Hepatitis C Awareness in the Welsh Assembly
  • Tales from the Archive
Publication size: .9 Mb
Download this document
Other material with the tag:Wales

Publications Library

  • Bridging the skills gap in the biopharmaceutical industry (2019)
  • Careers in the Pharmaceutical Industry
  • Economic and social impact of vaccines
  • Fighting back: How pharmaceutical companies are stepping up in the war against antimicrobial resistance
  • Public health benefit of vaccination
  • Rare diseases
  • The Future of Vaccines
  • Rare diseases: Facing three challenges

Theme

  • Devolved Nations - Cymru Wales

Type

  • Bulletin

ABPI

The Association of the British Pharmaceutical Industry is a company limited by guarantee registered in England and Wales 
(registered number 09826787) and its registered office is at 7th Floor Southside,105 Victoria Street, London, SW1E 6QT.
Telephone +44 (0) 207 9303477

© ABPI 2021
  • Twitter Logo
  • LinkedIn
  • YouTube Logo

Devolved Nations

  • Cymru Wales
  • Northern Ireland
  • Scotland

Quick Links

  • ABPI Exam
  • Disclosure UK
  • Frequently Asked Questions
  • Careers
  • Schools
  • Acronym buster

Website Info

  • Terms and conditions
  • Accessibility
  • Cookie Policy

Prescription Medicines Code of Practice Authority (PMCPA)

The Prescription Medicines Code of Practice Authority (PMCPA) was established by The Association of the British Pharmaceutical Industry to operate the ABPI Code of Practice for the Pharmaceutical Industry independently of the ABPI. The PMCPA is a division of ABPI which is a company registered in England and Wales (registered number 09826787) with its registered office at 7th Floor, Southside, 105 Victoria Street, London SW1E 6QT.

Office of Health Economics (OHE)

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 7th Floor Southside, 105 Victoria Street, London, SW1E 6QT. OHE provides independent research, advisory and consultancy services on policy implications and economic issues within the pharmaceutical, health care and biotechnology sectors.